The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 09, 2024

Filed:

Apr. 23, 2021
Applicant:

Rsem, Limited Partnership, Montreal, CA;

Inventors:

Przemyslaw Sapieha, Beaconsfield, CA;

Frédérick Antoine Mallette, Montreal, CA;

Malika Oubaha, Montreal, CA;

Normand Beaulieu, Montreal, CA;

Ariel Wilson, Montreal, CA;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/68 (2017.01); A61K 31/155 (2006.01); A61K 31/7088 (2006.01); A61K 38/17 (2006.01); A61P 3/04 (2006.01); C07K 16/28 (2006.01); C12N 15/113 (2010.01); C12N 15/62 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1138 (2013.01); A61K 31/155 (2013.01); A61K 31/7088 (2013.01); A61K 38/179 (2013.01); A61P 3/04 (2018.01); C07K 16/2863 (2013.01); C07K 2319/30 (2013.01); C12N 2310/111 (2013.01); C12N 2310/122 (2013.01); C12N 2310/531 (2013.01);
Abstract

Described herein are compositions and methods for modulating cellular senescence of a cell or induction of the senescence-associated secretory phenotype (SASP) in a cell. The methods generally comprise modulating the level or activity of IRE1a as a mean to control cellular senescence and induction of the SASP. Also described are methods for treating and preventing ocular vascular diseases comprising contacting cells in an eye of a subject with a biguanide compound and ophthalmic compositions comprising a biguanide compound.


Find Patent Forward Citations

Loading…